BridgeMD
New treatment option for Pulmonary Embolism
Official title PUlmonary REhabilitation in Patients Suffering From Post-PE Syndrome
ClinicalTrials.gov ID: NCT04615130
What this study is testing
- What it's testing
- This study is a multicenter, parallel, randomized waitlist-controlled trial that primarily focuses on the short-term benefit of outpatient pulmonary rehabilitation (PR) on patients after acute pulmonary embolism. Patients will be randomized into an intervention and a control group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Post-PE syndrome (except patients previously diagnosed with CTEPH) diagnosed by any of the following:
- Post-PE functional impairment criteria
- Post-PE Cardiac Impairment criteria
- Chronic Thromboembolic Disease criteria
- Possibility of starting rehabilitation between 12 and 36 weeks after the initial event of PE
You likely can't join if
- CTEPH diagnosis
- Chronic pulmonary diseases: COPD, interstitial lung diseases, asthma (only patients with severe asthma defined as a FEV1 ≤ 80% will be excluded), a...
- Active cancer
- Pregnancy
- Myocardial infarction or cardiac surgery one year prior to inclusion
- Congenital heart disease, congestive heart failure
See the full eligibility criteria
- Post-PE syndrome (except patients previously diagnosed with CTEPH) diagnosed by any of the following:
- Post-PE functional impairment criteria
- Post-PE Cardiac Impairment criteria
- Chronic Thromboembolic Disease criteria
- Possibility of starting rehabilitation between 12 and 36 weeks after the initial event of PE
- CTEPH diagnosis
- Chronic pulmonary diseases: COPD, interstitial lung diseases, asthma (only patients with severe asthma defined as a FEV1 ≤ 80% will be excluded), a statement on COVID-19 was amended due to the pandemic #
- Active cancer
- Pregnancy
- Myocardial infarction or cardiac surgery one year prior to inclusion
- Congenital heart disease, congestive heart failure
- History of stroke
- Any previous inpatient or outpatient PR Additional criteria that are absolute contraindications for pulmonary rehabilitation
- Acute and decompensated disease states with severe functional restrictions of various organ systems (e.g. heart, kidney and liver insufficiency, unstable angina pectoris, hemodynamically unstable arrhythmias, acute...
- open tuberculosis
- active infectious diseases and acute inflammatory processes
- Stressful and time-consuming therapy that significantly impair the ability to rehabilitate (e.g. chemotherapy or radiation therapy after malignancy)
- Participants who are not sufficiently resilient due to physical or mental impairment and / or cannot be mobilized and therefore cannot actively use the rehabilitation facility
- lack of motivation for therapy
- massive incontinence
- drugs and alcohol addiction
The study team makes the final eligibility decision.
Where it's taking place
- Vienna, Austria
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vienna, Austria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.